Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

FDA clears Sobi’s Gamifant for ‘hyper-inflammation’ disease

Approval adds to growing US portfolio

- PMLiVE

PEGASUS WINS AT PHARMATIMES COMMUNICATIONS TEAM OF THE YEAR AWARDS 2018

Pegasus was also highly commended in the NHS Communications Team category

Inizio

- PMLiVE

As Brexit looms, UK medicines agency head Hudson announces departure

Search for successor must start in early 2019

- PMLiVE

Reference price bill tabled in US House and Senate

The new measure could reduce median drug prices by around 43%

- PMLiVE

The power of behaviour change lies in the basics

‘Only with robust benchmarking can we address specific behaviour and make the right interventions to nudge the change’ 

Deal Watch October 2018

When writing this bimonthly edition of Medius’s Deal Watch I have been struck by how often the words 'it’s unusual...' have appeared. Most months we focus on the usual and...

- PMLiVE

Is AstraZeneca looking for its next CEO?

Shareholders said to want succession plan in place

- PMLiVE

Boston Scientific makes $4.2bn play for UK’s BTG

Comes shortly after the company acquired US biotech Augmentix

How to create an ethical pharma exhibition stand

At Apex, we have an enviable reputation when it comes to creating eye-catching and engaging exhibition stands that start conversations and boost sales. However, for heavily regulated industries such as...

Apex Events and Exhibitions

- PMLiVE

UK and EU’s future relationship ‘must protect patients’

UK coalition concerned about regulation, data sharing, infectious disease controls

- PMLiVE

Behaviour change – a missing ingredient?

‘Successful and impactful behaviour change requires huge commitment and time’

Porterhouse Medical is raising awareness for pancreatic cancer, here’s why…

Porterhouse Medical Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links